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Abstract
The history of biosensors began in 1962 with the invention of enzyme electrodes by Leland C. Clark.
Since then, biosensors have come a long way with simultaneous contributions in various fields such as
biology, chemistry, material science, electronics, physics and VLSI. With the advancement in science and
technology, smaller, more sensitive and dependable biosensors have become a reality. Still the need for
cost-effective, sophisticated, reliable, robust biosensors that can be used to detect multiple types of
biomolecules remains a technological challenge to be resolved.

The proposed AlGaN/GaN High Electron Mobility Transistors (HEMTs) have excellent prospect to
become the biosensor platform of the future, as is investigated in this work in contrast to other types of
biosensors. These devices excel over their silicon counterparts because of their inherent properties such as
chemically stable bulk and surface properties and the availability of high-density two-dimensional
electron gas (2DEG) at the hetero-interface which allows a highly sensitive detection of the surfacecharge related phenomena. Using a floating gate configuration, only the drain current changes pertinent to
biomolecule immobilization are observed. The test results are correlated with an analytical model which
provides insight into the device physics. The high mobility and sensitivity inherent in its material system
as well as device structure, robustness due to wide bandgap and system-level advantages make it the
ultimate choice as a biosensor platform.
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Chapter 1
Introduction
1.1

Introduction

The demand for diagnosing and monitoring of chemical and biomolecular analytes are increasing day by
day. Fast, reliable, ultrasensitive, portable sensor systems are of utmost importance for detecting these
analytes. Particularly, electrochemical biosensors demonstrate relative simplicity, portability, low cost
and low power requirement which make them excellent candidates for detecting a wide range of species,
including proteins, nucleic acids, small molecules and viruses. Because of the recent trend of point of care
application, this class of biosensors is rapidly becoming an important diagnostic tool. By incorporating
integrated systems, carefully optimized functionalization of the sensor is supported by associated
electronics, fluidics and separation technology. The potential for an extensive breakthrough of biosensor
platform technology is a real possibility.

This chapter describes the motivation and objective of the research and summarizes the outline of the
dissertation.

1.2

Motivation of Research

Modern day sensors have come a long way from their predecessors, which used transistors realized in
bulky semiconducting materials. Advent of micro-fabrication technology has led to the miniaturization of
biosensors. However, biosensors market is still characterized by slower pace of commercialization, which
is primarily attributed to high cost, availability of effective alternative technologies, and issues related to
stability, sensitivity, and quality assurance. Biosensors in medical and environmental applications still
remain a hugely untapped market, attracting researchers as well as entrepreneurs, with the hope of
leveraging dormant market opportunities.
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Potential applications of biosensors include:
1.

Food analysis

2.

Study of biomolecules and their interaction

3.

Drug development

4.

Crime detection

5.

Medical diagnosis (both clinical and laboratory use)

6.

Environmental field monitoring

7.

Quality control

8.

Industrial process control

9.

Detection systems for biological warfare agents

10.

Manufacturing of pharmaceuticals and replacement organs

Biosensors

Clinical

In vivo

Nonclinical

In vitro

Implantable
(Long term)

Invasive
(Short term)

Single shot

Multianalyses

Artificial
organs

Bedside
glucose
monitoring

Home
glucose
monitoring

Pathology
lab glucose
monitoring

Single
analysis

Fruit
ripening

Reactive
Monitoring

Pollution
monitoring

Figure 1.1: Potential applications of biosensors.
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Environmental
Bioagent
detection
Anthrax,
cholera,
plague

The global market for biosensors is projected to reach US $18.9 billion by the year 2019 from US $9.9
billion in 2012, at a compound annual growth rate of 9.6% [1]. Recent trends show that medical
applications remain the dominant field in the global market for biosensors. Percentage revenue in
worldwide biosensor market is shown in Figure 1.2.

6.8% 2.6%

Point of Care

11.2%
47.9%
12.6%

Home Diagnostic
Environmental

19.2%

Research Laboratories
Process Industries
BioDefence

Figure 1.2: Global biosensor market in 2009 [2].

A robust, sensitive, cost effective biosensor platform can reap the benefits of leading the way in this
emerging field. The proposed AlGaN/GaN high electron mobility transistors as investigated in this work
have excellent prospect of becoming the biosensor platform of the future in contrast to other types of
biosensors. Its high mobility and sensitivity inherent in its material system as well as device structure,
robustness due to wide bandgap, and system level advantages makes it the ultimate choice for biosensor
device.
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1.3

Biosensors

According to International Union of Pure and Applied Chemistry (IUPAC), a biosensor is a selfcontained integrated device that is capable of producing specific quantitative or semi-quantitative
analytical information using a biological recognition element which is in direct contact spatial with a
transducing element.

A biosensor uses specific biochemical reactions to detect chemical compounds in biological samples. It
comprises verily of two elements: a biological recognition element that interacts with the target analyte,
and a transducing element that converts the recognition event into measurable signal.

Electrical signal

Signal processing

Transducer

Transduction

Physiochemical signal

Bioreceptor

Recognition

analyte
analyte

Complex matrix

Figure 1.3: Components of a biosensor.
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In a biosensor, the biological recognition element is immobilized in the vicinity of the transducing
element, which is known as functionalization. This immobilization can be done by physical entrapment of
chemical attachment. Immobilized biological recognition element attracts specific target analyte, and the
recognition event is converted into measurable signal via transducer. The transducer might then send the
signal further signal processing unit.

Bioreceptor

Transducer

Bioreceptor

Transducer

Analyte
Analyte

Recognition
signal

No
Recognition
signal

Figure 1.4: Specific recognition using biological recognition element is the basic of biosensor.

Sensitivity and selectivity are the two most important performance factors in a biosensor. A biosensor
must be selective enough to ensure specific detection, as well as highly sensitive to convert the
biorecognition event into useful measurable signal. The selectivity is ensured by using proper
bioreceptors for functionalization, while sensitivity largely depends on the choice of device type used.
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1.4

Research Objectives

As described in the previous sections, a suitable, robust, sensitive biosensor platform that can be used for
multiple biomolecules can go a long way in the fairly untapped biosensor market. This work investigates
the prospect of AlGaN/GaN HEMT as a biosensor in comparison with two other types of biosensor
platform, namely nanofiber based biosensors and cantilever based biosensors. The superiority of the
HEMT based biosensors over the other two types has been demonstrated. A physics based model to
predict the behavior of the proposed bioFET is proposed to be developed. The model is validated using
experimental data. The existing models of AlGaN/GaN HEMT found in the literature [3, 4] can be also be
improved by considering the effects of polarization which serves as the key mechanism to induce the
carriers in AlGaN/GaN HEMT devices. The physics based model is then modified for floating gate
configuration to predict the behavior of the proposed HEMT based biosensor platform.

1.5

Outline of Dissertation

The second chapter of the dissertation contains the literature review on the history and types of bioFET.
Chapter 3 presents two biosensor platforms which have been physically realized, and their pros and cons.
Chapter 4 describes the advantages of HEMT device as a bioFET along with experimental data. Chapter 5
contains the charge control model of the proposed HEMT device, while chapter 6 describes the floating
gate model of the device when configured as a bioFET. Original contributions and future work outlines
are discussed in Chapter 7.
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Chapter 2
Literature Review
2.1

Introduction

Technological advancement heavily relies on the estimation, monitoring and control of relevant chemical
species. A major portion of this intelligence is acquired via sophisticated central laboratories. Nonetheless
portable, sensitive and readily available sensor platforms are required in many circumstances, especially
in clinical applications, where timeliness in both testing and monitoring of analytical markers are critical
for diagnosis of the disease and patient treatment.

This chapter focuses to give a brief review of biosensor technology over the last five decades. Different
types of biosensors, their desirable features and challenges that impede the advance in this field are also
discussed.

2.2

A Brief History of Biosensors

L. C. Clark Jr., the father of the biosensor concept, first described a biosensor platform based on oxygen
electrode in 1956 [5]. In 1962, he proposed an efficient method to make electrochemical sensors (pH,
polarographic, potentiometric or conductometric) by introducing enzyme transducers as membrane
enclosed sandwiches. The concept was illustrated by trapping glucose oxidase at a Clark oxygen electrode
using dialysis membrane and observing the oxygen concentration level. The decrease in measured oxygen
concentration was proportional to glucose concentration. Clark's glucose sensor was first launched as a
commercial sensor in 1973. But it became a commercial success in 1975 with the re-launch of the Yellow
Springs Instrument Company (Ohio) glucose analyzer based on the amperometric detection of hydrogen
peroxide.
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Guilbault and Montalvo [6] were the first to detail a potentiometric enzyme electrode. They described a
urea sensor based on urease immobilized at an ammonium-selective liquid membrane electrode. The use
of thermal transducers for biosensors was proposed in 1974 and the new devices were christened thermal
enzyme probes [7] and enzyme thermistors by Mosbach [8], respectively. In 1975, Divis [9] suggested
that bacteria could be harnessed as the biological element in microbial electrodes for the measurement of
alcohol.

Lübbers and Opitz [10] coined the term optode in 1975 to describe a fiber-optic sensor with immobilized
indicator to measure carbon dioxide or oxygen. They extended the concept to make an optical biosensor
for the continuous measurement of chemical concentrations in a biological system using a fiber-optic
oxygen sensor [11]. Commercial optodes exhibit excellent performance for in vivo measurement of pH,
pCO2 and pO2, but enzyme optodes were not yet widely available. In 1976, Clemens et al. [12]
incorporated an electrochemical glucose biosensor in a bedside artificial pancreas and this was later
marketed by Miles (Elkhart) as the Biostator. Although the Biostator is no longer commercially available,
a new semi-continuous catheter-based blood glucose analyzer has recently been introduced by VIA
Medical (San Diego). In the same year, La Roche (Switzerland) introduced the Lactate Analyzer LA 640
in which the soluble mediator, hexacyanoferrate, was used to shuttle electrons from lactate dehydrogenase
to an electrode. Although this was not a commercial success at the time, it turned out in retrospect to be
an important forerunner of a new generation of mediated-biosensors and of lactate analyzers for sports
and clinical applications. A major advance in the in vivo application of glucose biosensors was reported
by Shichiri et al. [13] who described the first needle-type enzyme electrode for subcutaneous implantation
in 1982. The idea of building direct immunosensors by fixing antibodies to a piezoelectric or
potentiometric transducer had been explored since the early 70’s, but it was a paper by Liedberg et al.
[14] that paved the way for commercial success. They described the use of surface plasmon resonance to
monitor affinity reactions in real time. The BIAcore (Pharmacia, Sweden) launched in 1990 is based on
this technology. In 1984, a method was described to use ferrocene and its derivatives as an immobilized
8

mediator for use with oxidoreductases [15] in the construction of inexpensive enzyme electrodes. This
formed the basis for the screen-printed enzyme electrodes launched by MediSense (Cambridge, USA) in
1987 with a pen-sized meter for home blood-glucose monitoring.
Academic journals contain descriptions of a wide variety of devices exploiting enzymes, nucleic acids,
cell receptors, antibodies and intact cells, in combination with electrochemical, optical, piezoelectric and
thermometric transducers1, [16]. Within each permutation lies a myriad of alternative transduction
strategies and each approach can be applied to numerous analytical problems in health care [17], food and
drink [18], the process industries [19], environmental monitoring [20], defense and security. Generic
goals may be identified which underpin more applied biosensor programs and tackle some of the principal
hurdles to the more widespread adoption of biosensor technology for analysis. Design of integrated
systems as well as approaches to patterning sensitive elements and methods for improving the sensitivity,
stability and selectivity of the biosensors are the key areas of biosensor research.

2.3

Different Types of Biosensors

Biosensors comprise a combination of three building blocks: a biological or physiological system;
instrumentation or sensing system; and an electrical and electronic system. The biological or
physiological system refers to the preparation of the target analyte and modifying the sensor system for
detection, the instrumentation or sensing system refers to the instrument, fitted with highly sensitive and
accurate sensors, and the electrical and electronic system refers to the associate circuitry which manages
the signal processing and the conversion to an analog/digital display.
Based on this basic platform, a number of different technologies have been developed to construct
biosensors, not all of which are used in all application types. Figure 2.1 describes the key biosensor
technologies that are currently in use. Different biosensors exploit different inherent properties such as
physical, chemical, electrical, mechanical or optical properties of the sensing material.
9

BioSensor Technologies

Electrochemical

Potentiometer

Bioluminescent

Amperometric

Piezoelectric

Resonant mirror

Surface Plasmon
Resonance

Conductometric

Crystal Resonance
Frequency

Opto-electric

Surface
Transverse wave

Fiber
Optic

Thermistor

Light Addressible
Potentiometric

Surface
Acoustic Wave

Figure 2.1: Different types of biosensors.

2.4

Desired Features of Biosensors

2.4.1

Sensitivity

Clinical applications, food technology and environment monitoring demand increased sensitivity and
detection range for various analytes. While the precise demands to meet today’s requirements may be
modest in these respects, the long term benefits of reliable detection of trace amounts of various
indicators, additives or contaminants is uncontended. With the advent of atomic force microscopy, single
molecule detection in the research laboratory is possible, but great strides have also been made with
conventional sensors for the detection of the analytes of interest. Enzyme electrodes have been designed
which preconcentrate the target analyte [21]. A gas-phase microbiosensor has been reported for phenol in
which polyphenol oxidase was immobilized in a glycerol gel on an interdigitated microelectrode array
[22]. Ultra-low detection limits are achievable with affinity sensors and electrochemical detection may be
readily integrated with chromatographic techniques to yield user-friendly devices [23]. In an alternative

10

approach, double-stranded DNA may be used as a receptor element. "Sandwich"-type biosensors based
on liquid-crystalline dispersions formed from DNA-polycation complexes may find application in the
determination of a range of compounds and physical factors that affect the ability of a given polycation
molecule to maintain intermolecular crosslinks between neighboring DNA molecules [24].

2.4.2

Stability

The most obvious disadvantage in exploiting the exquisite specificity and the sensitivity of complex
biological molecules is their inherent instability. Many strategies may be employed to restrain or modify
the structure of biological receptors to enhance their longevity. The effectiveness of sol-gels as an
immobilization matrix in an optode for glucose to enhance the stability of the glucose oxidase catalyst has
been demonstrated [25]. Some desirable activities, however, remain beyond the reach of the current
technology.

2.4.3

Selectivity

The selectivity of the biosensors can be improved by adopting two different methods; the interface
between the transducer and the biological receptor may be made more exclusive thus reducing
interference, and new receptors can be developed with improved or new affinities. The use of mediators
as a strategy to improve performance in amperometric biosensors has also been proved extremely
popular. Alternatively, electrocatalytic detection of the products of enzymatic reactions may be enhanced
by the use of chemically modified electrodes such as rhodinised [26] or hexacyanoferrate-modified [27]
carbon. Arguably a more elegant solution is to seek connection of the redox center of an enzyme to an
electrode via a molecular wire. Much has been published about these "wired" enzymes, but the literature
has generally been concerned with immobilized mediators on various polymer backbones. Novel
heteroarene oligomers, consisting of two pyridinium groups, linked by thiophene units of variable length
(thienoviologens) are promising candidates for such conducting molecular wires and may be used in
conjunction with self-assembly techniques to produce an insulated electrode which transfers electrons
11

specifically along predetermined molecular paths [28]. This design should produce enzyme electrodes
free from electrochemical interference. Advances in computational techniques now allow us to model
both electron transfer reactions and receptor binding interactions with increasing accuracy. This not only
enhances our understanding of the receptor/transducer interface, but allows us to consider designing new
receptors based on biological molecules.

2.5

Challenges in Biosensor Technology

In spite of a number of innovative biosensors developed to date, the biosensors market is still far from
meeting some of the key end-user needs. The key features that are yet to be implented include:


development of biosensors capable of multitest detection and monitoring



development of integrated biosensing platforms



development of a self-configuring biosensor



complete multiproduct, multivendor interoperability among biosensors



migration to lab-on-chip biosensors



availability of wireless options

There are various issues that hinder the growth of biosensor technology. To begin with, the lifespan of a
biomolecule is usually limited which calls for rapid detection. The readout time greatly varies from one
biosensor to another. In certain cases, the readout time can be as long as 20 seconds. Most biosensor
requires chemical pre-treatment prior to any kind of detection, which slows down the detection process.
Long term stability and miniaturization issues of the sensors still remain unsolved, which in term reduces
the cost-effectiveness of the sensors for commercial applications. Moreover, most biosensing techniques
require bulky optical instruments which are not suitable for point of care applications. Rugged biosensors
that can work in extreme environments to monitor vital signs also have limited availability.
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Considering all these technical challenges, it can be concluded that there is a great need for a portable,
miniature, robust, sensitive biosensor platform.
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Chapter 3
Electrode and Transistor Based Biosensor Platforms
3.1

Introduction

Biosensors were first developed based on electrode conduction principle. As such, most commercial
biosensors found to date are also based on the similar technique. But to reap the benefits of inherent gain
of transistors and to provide easy integration with data processing circuitry, transistor based biosensors
are gaining more popularity nowadays. This chapter gives a description of two different types of
biosensor platforms that has been tried with their working principle and experimental data collected. The
first type is based on electrode conduction, where carbon nanofibers are used as electrodes. The second
type is cantilever based, where the microcantilever at the base of a transistor is used for detection and the
advantages of a transistor based system is also utilized.

3.2

Glucose Sensor Based on Vertically Aligned Carbon Nanofibers

Carbon electrodes have been proven successful when used as enzymatic biosensors in terms of wide
range of functionality and cost effectiveness. Among the carbon electrodes carbon nanostructures
(cylindrical or conical structures) demonstrate the best potential. These carbon nanostructures have
diameters varying from a few nanometers to hundreds of nanometers and lengths ranging from less than a
micron to a few millimeters [29]. Although

carbon nanotubes (CNTs) have been widely used in

biosensor research, carbon nanofibers (CNFs)are emerging as a potential candidate to replace CNTs.
CNFs have excellent conductive and structural properties comparable with CNTs that make them
excellent candidates as electrodes as well as immobilizing substrates[30], [31]. CNTs and CNFs can be
used as electron field-emission sources, electrochemical probes, functionalized sensor elements, scanning
probe microscopy tips, hydrogen and charge storage devices, catalyst support, and nanoelectromechanical
systems (NEMS). Only the tips of the CNTs are active owing to their extremely regular shapes. In
contrast, a CNF has many irregularities and defect sites with exposed carboxyl groups throughout their
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surfaces, which serve as excellent locations for electrochemical charge transfer [32]. These result in better
sensitivity and responsiveness in the CNFs compared to the CNTs [33]. Because of superior structural
properties the CNFs also have better mechanical stability than the CNTs [34].

Because of the clinical significance, substantial research and development efforts have been devoted to
the development of reliable glucose sensors. Most of the proposed glucose sensors rely on amperometric
enzyme electrodes based on glucose oxidase (GOx).Oxidase based biosensors depend on the
immobilization of the oxidase enzymes and the co-enzymes on the surface of the electrodes and the
subsequent detection of the current associated with the redox product in the biological reaction. Mediator
based glucose sensors are also proposed in literature where artificial mediators and permselective coatings
are introduced in biosensor fabrication to increase the selectivity and the sensitivity of the amperometric
biosensors [35, 36]. Use of some of the mediators is limited by stability and toxicity while the
permselective membranes show effective but incomplete rejection [37, 38].

An attractive way to improve the performance of the glucose sensor is to use an enzyme wiring technique.
Enzyme wiring improves the electrical contact between the redox center of the electrode surfaces and
glucose oxidase (GOx) [39]. Due to similar dimensions of the nanoparticles and the redox proteins such
nanomaterials can be used for effective electrical wiring of redox enzymes. Various types of
nanomaterials such as gold nanoparticles [40], carbon nanotubes (CNT) [41] have been used as electrical
connectors between the electrodes and the redox centers of the GOx. Carbon nanotubes (CNT) can be
coupled to the enzymes to provide a favorable surface orientation and can act as an electrical connector
between their redox centers and the electrode surfaces. Patolsky et al. demonstrated that the aligned
reconstituted GOx on the edge of the single-wall carbon nanotubes (SWCNT) can be linked to an
electrode surface [41]. Various glucose biosensors based on CNT have been proposed taking the
advantage of this excellent property of ‘plugging’ of the electrode with GOx [42], [43]. Due to their
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superior sensitivity compared to CNTs, VACNFs can be easily used to build glucose biosensors based on
this enzyme wiring technique.

3.2.1

Working Principle

In general the oxidase-based biosensors depend on the immobilization of oxidase enzymes and coenzymes on the surface of the electrodes and the subsequent detection of the current associated with the
redox product in the biological reaction. Total workflow of the proposed glucose biosensor system is
shown in Figure 3.1.

Enzyme wiring / Electrode plugging

Glucose oxidase
(GOx) and
Horseradish
peroxidase (HRP)
VACNF electrode
Oxide coating
Chromium electrode
Silicon substrate

Figure 3.1: A cross sectional view of the fabricated VACNF based biosensor. The biosensor is prepared by coimmobilization of HRP and GOx on the VACNF surface. Chromium electrode was plugged with the GOx through
VACNF by the enzyme wiring technique.

Initially GOx functions as an enzyme and binds the β-D-glucose on the VACNF/HRP/GOx electrode
surface. Next the GOx catalyzes the oxidation process and transform β -D-glucose to D-glucono-1, 5lactone, which is then hydrolyzed to gluconic acid:
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Glucose + O2 GOx

 Gluconic Acid + H2O2

(3.1)

The reduction process corresponds to the electrocatalytic reduction of hydrogen peroxide (H2O2) by the
co-enzyme horseradish peroxidase (HRP) (equations 3.2 – 3.4) [43, 44]. The reduction reaction can be
shown as:

H 2O2  2H   2e HRP

 2H 2O

(3.2)

This reduction reaction can be divided into two reactions where HRP actively catalyzes the process [43,
44]:
HRP( Fe 3 )  H 2O2  compound _ I  H 2O

(3.3)

compound _ I  2e  2H   HRP( Fe3 )  H 2O

(3.4)

Hydrogen peroxide (H2O2) resulting in this process is used for the reduction reaction. HRP is a co-enzyme
which has accessible active sites. As a result the electron donors and the acceptors can participate in the
reaction where HRP plays the role of a catalyst. The reduction process corresponds to the electrocatalytic
reduction of H2O2 by HRP produced by the oxidation process (see equations 2 - 4). Electrons required for
the reduction process are supplied externally by the Cr electrode via VACNFs to the reaction centers. If
the current associated with the flow of electrons due to the redox reactions can be measured, it can
directly be correlated with the amount of glucose present in the biosensor system. Thus glucose detection
is possible by measuring the reduction current only.

3.2.2

Experimental Setup

A bienzymatic biosensor is prepared by co-immobilizing HRP and GOx on the VACNF surface. To
confine the chemicals to the area of interest, a well is formed around the nanofiber forests. The amounts
of HRP and GOx are chosen in such a way that they can cover the entire surface area of the VACNF
forest. Then the entire sensor chip is dried using a vacuum pump. When not in use all the modified
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electrodes are stored at 4°C in phosphate buffer saline (PBS). The Cr electrode was plugged with the GOx
through the VACNF via enzyme wiring technique to facilitate an efficient way to transfer electrons from
the electrode to the reaction centers. A CHI 666A electrochemical analyzer was used for measurement.
The tungsten working electrode (cathode) was connected to the VACNF and the tungsten reference
electrode (anode) and the counter electrode were connected to the solution, as shown in Figure 3.2.

Figure 3.2: Test setup for the glucose sensor using VACNF electrode.

3.2.3

Results and Discussion

Figure 3.3 represents the amperometric response of the VACNF/HRP/GOx glucose sensor. In the absence
of glucose, application of a potential between the electrodes results in a current flow between them.
Addition of glucose to the system induces a flow of reduction electrons, which opposes the initial flow of
current. This is represented by the overall decrease in measured current. This result is similar to the result
reported by Wu et al. [38].
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Figure 3.3: Amperometric response of VACNF/HRP/GOx biosensor in 0.1 M pH 7.4 PBS in the addition of 4 mM
glucose. The biosensor responded immediately with the addition of glucose. Initial potential was set to -0.4 V.

3.3

Anthrax Sensor Based on Microcantilever

Microorganisms have been in existence for billions of years and their importance in environmental
processes and human activities is well recognized. Certain bacteria, notably those of the Bacillus and
Clostridium groups, differentiate spores that are highly resistant to chemical and physical insults. Spores
of these certain species demonstrate persistent attachment to inert and negatively charged surfaces.
Development of a lightweight and spore-specific sensor is very useful for early detection of the presence
of bacterial spores.

Biomolecule detection can be achieved by the immobilization of biomolecules on a chemically treated
cantilever which affects the performance of the embedded MOSFET. Targeted binding of the biomolecule
generates stress on the cantilever which creates interface defects and traps in the channel region of the
embedded MOSFET, thereby reducing mobility. Different designs including the orientation of the
cantilevers with respect to the embedded MOSFET have been adopted to maximize the stress effects on
the characteristics of the MOSFET [46].
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3.3.1

Working Principle

For the cantilever along the transversal direction of the current flow in the MOSFET [47], the transverse
tensile stress dominates the compressive longitudinal stress. The change in the channel resistance due to
the applied stress can be written as [46],

R
  t t   l l
R
Here the subscripts t and l stand for transverse and longitudinal directions, respectively. The combined
effect of the variations of the piezoresistive coefficients (-πt, +πl) and the stress components (-σt, +σl) in
the cantilever due to the adsorption of target molecules results in increased channel resistance (reduced
mobility) and therefore reduced drain current. Overall, the embedded structure shows high sensitivity (1-2
μA/nm) enabling the detection of 5 to 10 nm deflections of the cantilever [47].

3.3.2

Experimental Setup

Microcantilevers are fabricated as arrays, where cantilevers of SiNx and SiNx with thin gold coated layer
are placed in an alternating fashion. The embedded MOSFETs are located at the base of the cantilevers
where stress due to adsorption is the maximum.

Figure 3.4: SEM image of two identical cantilevers displaying embedded MOSFET and geometry of the goldcoated and SiNx cantilever beam pair [47].
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For microbial sensor a MOSFET at the base of a SiNx microcantilever works as the reference whereas a
MOSFET at the base of a SiNx microcantilever with a thin coating of gold is used as the probe as shown
in Figure 3.4. The differential drain current between the probe and the reference microcantilevers, which
further minimizes systematic noise and environmental perturbations, forms the basis for the anthrax
simulant detection due to selective adsorption to the gold-coated probe.

For the experiments, the MOSFET-embedded microcantilevers were first characterized to obtain the drain
current versus the drain-to-source voltage curves to be used as reference as shown in Figure 3.4. Then,
both the bare SiNx and the gold-coated cantilevers were submerged in a phosphate buffer solution (PBS)
to chemically treat the cantilevers for anthrax simulant attachment. Effect of the buffer solution
application was observed by taking the characteristic curves of both MOSFETs. Afterwards 15µL of
anthrax simulant solution (suspension population of 1.3 x 107 Colony Forming Unit/ml diluted in 40%
ethanol and 60% de-ionized water) was applied over the cantilever MOS pairs in doses of 5µL.
Characteristic curves were obtained after each dose application. Under the microscope the bending of the
gold-coated cantilever was clearly visible whereas the silicon nitride cantilever remained unaffected. It
was noticed that the anthrax simulant spores were attracted to the voltage supplying probes when voltage
was applied to obtain characteristic curves. Signatone Checkmate probe station and HP 4155B parameter
analyzer were used for collecting the measurement data.

3.3.3

Results and Discussion

Before the application of phosphate buffer solution (PBS) both the SiNx and gold-coated cantilever MOS
structures demonstrate similar characteristic curve as shown in Figure 3.5a. Application of PBS causes the
gold cantilever to bend as it gets attached to the gold surface while SiNx cantilever remains unbent. The
effect of applying PBS on the MOSFET drain current, as one cantilever bends and the other remains
unbent is shown in Figure 3.5b.
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(a)

(b)
Figure 3.5: a) Characteristic curves of SiNx and gold coated cantilever MOS at applied gate voltage of V G = 5V, b)
responses of Au and SiNx MOSFETs with VG = 5V in buffer solution.

Due to selective adsorption, anthrax stimulant adhere to only the gold-coated cantilevers and probe
MOSFET experiences stress and subsequent drain current reduction phenomenon. SiNx cantilevers do not
adhere to biomolecules, therefore the reference MOSFET do not show any change in current.

3.4

Conclusion

Although both the VACNF and microcantilever based sensors provide promising results, they fail to
provide for the demands of the rugged, simplistic biosensors that can be commercialized, at least at their
current state of development. Nanofiber based sensors require complex imprint technology, and the
integration with CMOS circuitry is also difficult. Microcantilever based sensors can utilize the benefits of
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transistor based systems and can be readily integrated with CMOS circuitry for signal processing, but
they lack mechanical stability and thus cannot be used for high concentration biomolecule samples. The
target biomolecules must be diluted, thereby requiring an extra step in the sensing process. Also, since
they use strain on the cantilever, they are more susceptible to give a false alarm if some dust or unwanted
particles falls on the cantilevers. As such, there still remains the need for a truly transistor based system
where the biomolecules will interact with the sensor electrically.
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Chapter 4
High Electron Mobility Transistor as BioFET Platform
4.1

Introduction

In this chapter, the advantages of AlGaN/GaN high electron mobility transistor (HEMT) as a bioFET are
explained. While compared to the biosensor platforms presented in chapter 3, the HEMT based biosensor
platforms demonstrate chemical and surface stability, high sensitivity towards surface charge phenomena
to become the ultimate choice. Two different types of biomolecules, one from plant (photosystem I, or PS
I) and one from human body (Human Monokine induced Interferron Gamma, or human MIG) are
detected by the HEMT devices configured as biosensor. The experimental data shows excellent promise
to differentiate between the presence and absence of target biomolecules.

4.2

HEMT Structure

Of the various device FET structures, HEMT devices show better performance as high-power and highfrequency devices. Capacitive modulation of the channel charges is the basic principle of operation for all
the FET devices. With this common concept, use of different geometries, different materials and doping
profiles results in the variety of FET transistors. Eventually, each type of FET would differ in the
confinement of the channel charges and the isolation between the gate and the channel, which would
result in a novel device with specific properties. The first HEMT was based on GaAs/AlGaAs
superlattices pioneered by L. Esaki and R. Tsu at IBM in the late 1960’s [48]. They proposed that by
modulation doping, a process where electrons are transferred from highly doped and wider bandgap
material (AlGaAs) to a lightly doped material (GaAs), high mobilities in GaAs is achieved [48]. R.
Dingle, H. L. Stormer, A. C. Gossard, and W. Wiegmann of AT&T Bell Labs, working independently,
demonstrated high mobilities in a GaAs-AlGaAs superlattice in 1978. Realizing the high performance
capability of such a structure of the field-effect transistor, researchers of various labs in the United States
(Bell Labs, University of Illinois, and Rockwell), and Japan (Fujitsu), and France (Thomson CSF) started
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working on this device. In 1980, the University of Illinois and Rockwell first fabricated such a device
with a reasonable microwave performance, which they named as modulation-doped FET or MODFET.
The same year researchers at Fujitsu reported the results for a device with a 400-pm gate. They called the
device “high electron mobility transistor” or HEMT. Thereafter, Thomson CSF and Bell Labs followed
calling their realizations a “two-dimensional electron gas FET” or TEGFET, and “selectively doped
heterojunction transistor” or SDHT, respectively [48].

In conventional metal-semiconductor FET’s (MESFET’s), the donor impurities generate the electrons
(carriers) and reside in the same space/layer with the electrons. As a result, the conducting electrons start
colliding with the impurities. For higher speed, more current is required which necessitates larger
concentration of electrons. This leads to more electron-donor interaction, called ionized impurity
scattering.

In addition, thinner channel layers and higher electron concentrations are required for smaller FET size.
The isolation of large electron concentration with donors can be obtained by employing heterojunctions.
A heterojunction is formed between two different bandgap materials such as AlGaAs and GaAs. The
donors are introduced only into the larger bandgap (AlGaAs) material [49], [50]. The electrons originally
introduced into the larger bandgap layer (AlGaAs) diffuse to the lower energy (GaAs) layer where they
remain confined due to the energy barrier at the heterointerface as illustrated by the band diagram in
Figure 4.1.

Thus, a 2-dimensional electron gas (2-DEG) is formed at the heterointerface very close to the gate, which
leads to very high electron mobilities and large electron velocities at very small values of drain voltage
[51].
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Figure 4.1: (a) Schematic diagram of an AlGaAs/GaAs HEMT structure, (b) Energy band diagram of the HEMT
device showing the formation of the 2 dimensional electron gas in the quantum well.
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In 1993, Asif Khan et al. first demonstrated a HEMT based on AlGaN and GaN heterojunctions [52].
Since then much progress has been made for the achievement of better performances of AlGaN/GaN
HEMT. AlGaN/GaN exhibits improved ratings for power and frequency applications compared to
AlGaAs/GaAs HEMT. This is due to the superior intrinsic properties of GaN material compared to GaAs
as evident from Table 4.1 and also due to the polarization effects dominant in AlGaN and GaN materials.

Table 4.1
Comparison of Different Semiconductor Materials

SemiConductor

Eg

µ

(eV)

(cm /
V-sec)

Si

1.1

1300

GaAs

1.4

SiC
GaN

2

εr

Ec

vs
7

λ

Tmax

(W/cmK)

( C)

o

(kV/
cm)

(10 x
cm/sec)

11.4

300

1

1.5

300

5000

13.1

400

1

0.46

300

2.9

260

9.7

2500

2

1.49

600

3.4

1500

9.5

2000

2.2

1.3

700

GaN has both Zincblende nad Wurtzite crystalline forms. It is normally grown on the Ga-face, along its caxis. It has a substantial spontaneous electrical polarization perpendicular to the hexagonal plane, and in
the direction down into the Ga-face surface. When AlxGa1-xN is grown on GaN, larger electrical
polarization results in the same direction. AlxGa1-xN has a smaller lattice constant, so that the two-
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dimensional tension causes a piezoelectric effect which adds to the spontaneous polarization [53]. A
positive sheet charge density appears due to the net polarization effect, which causes an accumulation of
electrons at the interface and thus forms the 2-DEG as shown in Figure 4.2. Thus, even without any
intentional doping in the AlGaN layer, a high charge density channel is formed at the heterointerface.

4 µm
0.2 µm
Source
n+ GaN

Drain

Gate Metal
20 nm

UID AlGaN n+ GaN

2-DEG
2 µm
UID GaN
Substrate

Figure 4.2: AlGaN/GaN HEMT structure and the formation of 2DEG.

4.3

Advantages of AlGaN/GaN HEMT as a BioFET

The AlGaN/GaN high electron mobility transistor (HEMT) devices are focus of increasing interest as
biologically modified field effect transistor (BioFET) based micro- and nano-electronic sensor platforms
in recent years. They excel over their counterparts because of their inherent properties such as: (i)
chemically stable bulk and surface properties, (ii) a high-density two-dimensional electron gas (2DEG)
available at the hetero-interface which allows a highly sensitive detection of surface-charge related
phenomena, and (iii) as a piezoelectric material, its conductivity changes upon a change of the surface
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charge, such as that due to binding of antigen onto an antibody-functionalized surface11. These very
favorable material attributes significantly facilitate amplification of the current change pertinent to change
in the gate potential due to the proximity of the immobilized biomolecules and/or biomolecular binding
events between the charged biological molecules (e.g., antigen-antibody or receptor-analyte binding
events) at the high charge density sensing channel or the gate surface [54,55].

4.4

Experiments

4.4.1

Photosystem I

PS I reaction centers are potential sources of solar energy. Using sunlight, these reaction centers generate
electrical potentials which can be accumulated to build substantial source of electrical energy if proper
extraction technique can be developed. In oxygenic plants there are two types of reaction centers –
Photosystem I (PS I) and Photosystem II (PS II). Both of the reaction centers work in succession to
produce glucose for green plants, some bacteria and protists in photosynthesis. Photosynthesis is a two
phase process. The first phase is light dependent which requires direct energy of light to produce energy
carrier molecules. The second phase is light independent. During the first phase, light energy induces
electron separation in PS II. PS II fills the electron from a water molecule, breaking the water into H+ ions
and O-2 ions. These O-2 ions combine to form O2 molecule. The electron is boosted to a higher energy
state and finally transferred to PS I through electron acceptor and a series of redox reactions. The electron
is again passed through a series of redox reactions and eventually becomes attached to NADP+ and H+ to
form NADPH, which is the energy carrier in the light independent reaction. There is thus a continuous
flow of electrons from water to NADPH, which is used for carbon fixation in the light independent
process. Thus, PS I and PS II work as energy harvesting units in photosynthesis.

PS I RC/core antenna complexes containing about 40 chlorophylls per photoactive reaction center
pigment (P700) can be isolated efficiently from thylakoids of plant leaves (such as spinach) using the
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technique of detergent solubilization and hydroxylapatite column purification [56]. The isolated PS I
complexes are elliptical in shape with major and minor axes of about 6 and 5 nm, respectively [56].

FABFX
~1V

A1

~ 6 nm

A0
e-

P700+

Figure 4.3: Charge separation in PS I due to absorption of light.

The structure and the function of PSI reaction centers are schematically illustrated in Figure 4.3. An
isolated PS I complex contains photochemical charge center of P700 and electron acceptors of A0, A1, FX
and FAB. These electron acceptors serve as an antenna to capture photons and transfer photon energy to
P700.The light energy triggers photochemical charge separation in P700 creating P700+ and A−0 within
about 1.5ps [57].The electron released from P700 is transferred through intermediate acceptors A0, A1, Fx,
to the terminal acceptor FAB at the reducing side of the PS I. Due to efficient excitation transfer and
trapping, the entire photophysical chemistry can be completed in 10-30 ps. The quantum yield of PS I
photochemistry is very close to 100%. Charge separation in this natural photovoltaic device generates a
−
potential difference of about 1 volt across about 6 nm dimension between the reduced (FAB
) and the
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oxidized (P700+ ) sides of the PS I complex, resulting in a very strong electric field (~ –108 volts per
meter).

4.4.1.1 Functionalization of the BioFET
Organic SAMs on solid surfaces are one of the most suitable functional linkage-layers for the
immobilization of biomolecular complexes. To date, the SAMs of alkanethiols on Au surfaces are the
most intensively studied immobilizing systems. Functional PS I RCs can be selectively immobilized and
oriented by the chemical modification of the Au surface [56]. Two-dimensional vectorial arrays of
functional PS I RCs have been prepared on atomically flat derivatized Au surfaces [56]. The atomically
flat

Au

{111}

substrate

were

treated

with

mercaptoacetic

acid

(HSCH2COOH),

2-

dimethylaminoethanethiol [(CH3)2NCH2CH2SH], and 2-mercaptoethanol (HSCH2CH2OH) which form a
negative, positive, and hydrophilic surfaces, respectively. Then the substrates were incubated in PS I
solution and it was found that 65% of the area was covered with PS I when treated with mercaptoacetic
acid. The negatively charged end groups attract and orient PS I RCs on the substrate. Previous studies
have shown that the polar regions (both ends) of the PS I are positively charged [56]. These regions serve
as the docking sites for ferredoxin and plastocyanin, the natural electron acceptor and donor, respectively,
for PS I. On the other hand, very little PS I coverage was found (5.0%) on 2-dimethylaminoethanethiol
treated Au surface terminated with positively charged end groups [56]. When treated with 2mercaptoethanol, 70% of the area was covered with PS I. The treatment with 2-mercaptoethanol
terminates the surface with end groups that form hydrogen bonds with PS I arrays.
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Figure 4.4: Orientation of PS I molecules after treating the gate with Marcaptoacetic acid and 2-Marcaptoethanol.

In addition, PS I can be selectively oriented by the modification of a surface with the specific
organosulfur compounds/thiols [56].

For mercaptoacetic acid, 83% of the electron transport vectors

were found parallel to the surface, whereas with 2-mercaptoethanol 70% were oriented perpendicularly in
the “up” position with P700 facing the Au surface and only 2% were in the “down” position (Figure 4.4).
No preferential orientation was observed with 2-dimethylaminoethanethiol.

4.4.1.2 Experimental Setup
The surface of the AlGaN/GaN HEMT was treated with 2-mercaptoethanol to functionalize the PS I RCs.
After waiting for 30 seconds, the die was immersed in PS I solution and was kept in refrigerator for 24
hours. The DC current-voltage (I-V) characteristics have been measured by a Signatone Checkmate DC
probe station and a Keithley 2400 source meter. The measurements have been performed in floating gate
configuration, i.e., without any applied gate bias. The test conditions were kept identical before and after
the immobilization of RCs and as well as in the dark and in the light environments. A Labview program
was developed to measure the current-voltage characteristics in all conditions. The floating gate test setup is shown in Figure 4.5.
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Figure 4.5: Test setup used for the measurement purpose using Signatone Checkmate probe station. The devices are
configured in floating gate configuration, as can be seen above.

4.4.1.3 Test Results and Interpretation
The measured I-V characteristics of the HEMT device are shown in Figure 4.6. The drain current before
and after the immobilization of the PS I RCs is measured in both light and dark environments. Figure 4.6b
shows drain current after immobilizing PS I RCs before and after illumination. The net change in the light
and the dark characteristics of the HEMT due to the immobilization of PS I RCs on the gate is also shown
in Figure 4.6b. The charge separation mechanism due to light and the resultant changes in the drain
current are explained in Figure 4.7.

33

(a)

(b)
Figure 4.6: (a) Measured I-V characteristics before and after the immobilization of PS I in light and dark
environment, (b) Changes in the I-V characteristics of the device as a result of PS I immobilization and charge
separation in PS I RC under illumination.
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The orientation for most of the reaction centers on the 2-mercaptoethanol treated surface can be
determined by noticing the changes in the current directions due to PS I immobilization. As reported in
[56], 70-80% of PS I molecules on 2-mercaptoethanol-modified Au surfaces are oriented primarily with
the electron acceptor side (FAB) up and the donor side (P700) down (adjacent to the 2-mercaptoethanolmodified gate surface).
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Figure 4.7: Conceptual illustration of the effect of the dipolar nature of the RCs on the threshold voltage of the
HEMT device with immobilized PS I in (a) dark and (b) under light environment.
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Under illumination, the electric potential on the oxidizing side (P700) of PS I results in a positive voltage
following electron release, whereas in the dark the potential is negative with respect to the substrate [58].
Therefore, each of the reactions centers in the dark can be modeled as a dipole with negative terminal
near the substrate which in effect increases the threshold voltage of the HEMT and reduces the current
(Figure 4.7a). The current for PS I in dark is negative. Figure 4.6b is plotted by taking the magnitudes of
all three currents.
Under illumination, the current should have been reversed completely because of the inversion of dipole
polarities (Figure 4.7b). However, during measurement a percentage of the reaction centers become
denatured due to the oxygen in the atmosphere, and refrains the current from completely reversing its
direction. Figure 4.6a shows the net current of the HEMT in the presence of PS I under illumination.
Therefore, the difference in the light and the dark currents due to PS I provides a measure of the current
for charge separation across the photoactive reaction centers. The resulting current due to photon induced
redox process in the reaction centers is also shown in Figure 4.6b.

4.4.2 Human Monokine Induced Interferron Gamma
Although, organ and tissue transplantation is an increasingly important patient treatment option in a
number of disease conditions (for example, kidney, liver, skin, heart, etc.), the rate of allograft rejection
episodes is still quite high, occurring in approximately 20% of the recipients [59]. Thus, rejection of
transplanted organs or tissues constitutes impedance to the successful long-term treatment of some of the
disease conditions. Chemokines are a family of cytokines that have been shown to be crucial mediators of
immune reactions leading to transplant or allograft rejection [59]. Specifically, evidence from various
studies have clearly shown monokine induced by interferon-gamma (MIG/CXCL9) as playing a central
role among the chemokine proteins implicated in rejection of heart, skin and kidney tissue allografts.
MIG, a member of the CXC subfamily of chemokines is an inflammatory chemokine that play an
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important role in cell activation, and is produced during T-cell-mediated responses to inflammation
including allograft rejection episodes) [60,61]. Consequently, MIG is investigated as a target immune
response biomarker in transplant applications [60, 62, 63]. The range of MIG concentration in normal and
pathophysiological disease states (including allograft rejection episodes) in humans is ≈ 0.2-3 ng/mL and
10-400 ng/mL, respectively [64]. Due to the important role of MIG as a biomarker in transplant rejection,
there is a great need to develop biosensor technology platforms to sensitively detect MIG for early
monitoring of possible transplant rejection.

4.4.2.1 Functionalization of the BioFET
The sensing gate channel of the HEMTs have gold contact deposition, which is suitable for creating selfassembled monolayers (SAMs) to immobilize the biomolecules. The self-assembly method for anchoring
of the biorecognition molecules have a number of advantages relative to other approaches, namely, high
reproducibility, molecular level control, vicinity from the surface, allowing direct electron/charge
transfer[65]. Dithiobis(succinimidyl propionate) or DSP is a water insoluble, homobifunctional Nhydroxysuccinimide (NHS) ester that can form a self-assembled monolayer on a gold surface due to its
disulphide group [66]. The NHS group has primary amines as principle targets; consequently it has found
applications for the immobilization of biomolecular species (proteins, etc) containing primary amines to
gold surface [67]. The bisymmetrical DSP links to ε-amine groups on the α-amine position of N-terminal
amino acids. The succinimidyl ester of DSP is an ideal leaving group to electron donating primary
amines. Attack occurs at the electron deficient carbon of the ester on DSP by a primary amine to create an
amide bond in suitable pH range for the covalent immobilization of the protein on the gold surface. The
great advantage of building DSP SAMs in comparison to conventional methods [68, 69] is the elimination
of the chemical activation step in the covalent attachment of biomolecules containing primary amines to
create an amide bond (Figure 4.8).
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Figure 4.8: Schematic illustrating the formation of reactive DSP SAM on HEMT gold gate for covalent
immobilization of anti-MIG monoclonal IgG.

The vicinity of short DSP SAMs from the electrode surface has been used previously to obtain direct
electron transfer from redox copper centers [70]; DSP has spacer arm length of 12.0 Å or 8 atoms [71].
The short height of the SAM and the elimination of additional layers of chemical activating groups are
advantageous for FET sensing architectures where proximity of the binding antibody-antigen pairs to the
sensing gate surface is crucial for sensitive detection of the binding event.

4.4.2.2 Experimental Setup
Prior to any experimental work, the device was properly cleaned with acetone and ethanol and dried in
nitrogen flow. To create the SAM layer, the gold gate region was exposed to 1 mM solution of DSP for
two hours at room temperature. To remove the weakly absorbed DSP, the device was again washed away
using acetone. The reactive SAM layer created covalently binds the anti-MIG monoclonal IgG molecules
through their primary amine groups. To achieve immobilization, the gate was exposed to 25µL anti-MIG
1gG in phosphate buffered saline (PBS) at 40C for 24 hours. Rinsing the device with Tween 20 solution
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in PBS washes away the weakly bound anti-MIG. The change in the drain current due to the
immobilization of the anti-MIG was measured. The resulting molecular affinity interface IgG receptors
are then used for the binding and detection of the MIG. To accomplish this, the biofunctionalized gate
was exposed to 20 ng/mL human MIG in PBS (150 mM) and the change in drain current due to the antiMIG/MIG binding interaction was measured. The volume applied is 25µL. Similar measurement was also
carried out separately for 50 ng/mL MIG concentration. Before repeating the experiment with the same
device, it was properly cleaned to eliminate any trace of analyte from the previous experiments. The step
by step procedure is shown in Figure 4.9.

Gold plated
gate
Source

DSP

Anti-MIG

SAM
layer

Drain

HEMT

AntiMIG

HEMT

VDS

HEMT
48 hrs at 40C, then wash using
Tween 20 solution.

4 hrs at room temperature,
then wash using ethanol.

Measure the I-V characteristices
using Keithley 4200 semiconductor
parameter analyzer.

MIG

Anti-MIG

VDS

MIG

HEMT
Wash before proceeding
with another set of testing.

HEMT
Measure the I-V characteristices using
Keithley
4200
semiconductor
parameter analyzer.

Figure 4.9: Step by step procedure for testing using GaN/AlGaN biosensor.
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4.4.2.3 Test Results and Interpretation
After the formation of SAM layer, the device current was a little lower compared to that of the clean
device. This slight decrease in current may be due to the change in the gate surface after the SAM layer
was created. However, exposure to anti-MIG IgG changed the drain current significantly. The anti-MIG
molecules immobilized on the gate surface of the device impart specific biorecognition properties to the
HEMT BioFET sensor. As it has been reported that antigens elicit antibodies of opposite charge and that
the antigen-binding sites dominate the interface properties of IgG antibodies [72, 73], it is assumed that
the positive polarity of the anti-MIG IgG molecules lies adjacent to the gate surface.

VDS
Capacitive
coupling

Source

anti-MIG
Gate Metal

DSP SAM
layer

2-DEG

n+ GaN
0

Drain

UID AlGaN n+ GaN

x

Electron gained due to positive charge of
anti-MIG immobilized on gate surface

UID GaN

Figure 4.10: Increase in drain current after anti-MIG immobilization on gate.

Each positive charge on the gate surface induces a negative charge in the 2DEG due to capacitive
coupling and thus results in an increase in the gate current. This is schematically shown in Figure 4.10
and is confirmed by the measured data in Figure 4.12.
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Figure 4.11: Decrease in drain current due to loss of electron after MIG/anti-MIG binding.
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Figure 4.12: Measurement of drain current for clean device, after anti-MIG immobilization and after MIG exposure.
Current reduces by 1.9mA due to recombination of anti-MIG and MIG.
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The recombinant human MIG exposed to the device sensing gate binds specifically with the previously
immobilized anti-MIG IgG molecules. The corresponding changes in the net charge of the MIG/anti-MIG
complex modulate the electrical properties of the HEMT FET sensing channel. These results in loss of the
electron gained in the previous anti-MIG immobilization and cause a decrease in the drain current. As
already indicated above, this is shown in Figure 4.11 and is confirmed by the measured data in Figure
4.12. The experimental results confirm the sensitive detection of the MIG by the anti-MIG monoclonal
antibody.

Experiments were carried out using various concentrations of MIG, ranging from 5 ng/mL to 500 ng/mL.
It was observed that at low concentrations range the increasing MIG concentration decreased the
differential current due to anti-MIG/MIG recombination. As the anti-MIG concentration was held
constant, increasing MIG concentration results in a gradual increase in the drain current after
immobilization due to the presence of the positive charge on the MIG. As a result, the differential current
before and after the immobilization of MIG is gradually decreased as shown in Figure 4.13. Figure 4.14
represents the reproducibility of the result with three sets of test data at 5ng/mL concentration of MIG that
fall within the standard error bars.

As MIG concentration was further increased, the positively charged MIG dominates the net charge at the
gate. Due to the dominating positive gate charges, electrons are attracted to the channel resulting in the
increase in the drain current. Eventually the current after immobilization of the MIG becomes greater than
the current prior to the immobilization. As a result, the differential current increases in the negative
direction, which is confirmed by Figure 4.13.
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Figure 4.13: Decrease in differential drain current with increase in MIG concentration. Vds is kept fixed at 2 V.
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Figure 4.13: Standard error bars demonstrating the reproducibility of the results. The concentration of MIG was
maintained at 5ng/mL.
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4.5

Conclusion

Using the same device, a novel way for detecting two different kinds of biomolecules is demonstrated,
which promises the potential of detecting multiple biomolecule in a single chip. As such, the sensor can
be further developed for point of care applications for the detection of biomarkers of complex diseases
such as different types of cancers, where detecting only one or two biomarkers may give ambiguous
results. The device can be integrated with microfluidic channels to control the flow of target analyte to the
area of interest and with other signal processing and transmission circuitry to have a lab on a chip.

In addition, the results reported here is the first for the detection of native recombinant human MIG in
physiologically relevant buffer environment (150 mM PBS). This shows the potential of the devices for
use in the detection of biomarkers in an ionic strength environment corresponding to that present in
human blood. This possibility will eliminate the need for the extra steps required to extract the target
biomarkers and prepare diluted solution before detection.
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Chapter 5
Charge Control Model of HEMT
5.1

Introduction

This chapter focuses on the development of a physics based analytical model of AlGaN/GaN HEMT. The
development of 2D electron gas (2DEG) in HEMT structure is investigated in details. Both spontaneous
and piezoelectric effects of polarization in channel charge are considered. A quasi-triangular quantum
well is considered in the heterojunction. The sheet carrier density of the 2DEG is expressed via a nonlinear equation. The non-linear equation of charge is simplified based on realistic approximation and the
current voltage relationship of the HEMT device is developed. The effect of drift velocity and electric
field is also included via an empirical model.

5.2

Development of 2D Electron Gas in AlGaN/GaN HEMT

The crystalline structure of GaN can be both Zinc blende and Wurtzite (Figure 5.1). It is normally grown
on the Ga-face, along the c-axis.

Ga
Ga
N

N

c
c
b
a

b
a

Zinc blende
Structure
(a)

Wurtzite
Structure
(b)
Figure 5.1: Crystalline structure of GaN.
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Because of the noncentrosymmetry in its crystalline structure, GaN exhibits a substantial spontaneous
electrical polarization (Psp) perpendicular to the hexagonal plane, and in the direction down into the Gaface surface, as shown in Figure 5.2. When AlGaN is grown on GaN, larger electrical polarization results
in the same direction. Moreover, since AlGaN has a smaller lattice constant than GaN, the twodimensional tension at the interface induces a piezoelectric polarization component (Ppe) which adds to
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N-face
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[000ī ]

Ga-face

[0001]

the spontaneous polarization [53].
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Surface
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Figure 5.2: Polarization properties of AlGaN and GaN materials.
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The total electrical polarization (Pt) between the pseudomorphic AlGaN top barrier layer and the GaN
channel layer is obtained by the algebraic sum of individual components as given by equation 5.1.
𝑃𝑡 = 𝑃𝑠𝑝 (𝐴𝑙𝐺𝑎𝑁) − 𝑃𝑠𝑝 (𝐺𝑎𝑁) + 𝑃𝑝𝑒 (𝐴𝑙𝐺𝑎𝑁)

(5.1)

A positive sheet charge density (Q) appears due to the net polarization effect, which causes an
accumulation of electrons at the interface and thus forms the 2-DEG (Figure 5.3). Therefore, even without
any intentional doping in the AlGaN layer, a high charge density channel is formed at the heterointerface.

Source

n+ GaN

Drain

Gate Metal

Ppe

Psp

AlGaN

n+ GaN

2-DEG

Psp

UID GaN

Figure 5.3: Formation of 2DEG at AlGaN/GaN hetero-interface due to spontaneous and piezoelectric polarization.

Especially in wurtzite AlGaN/GaN based transistor structures; the piezoelectric polarization of the
strained top layer is more than five times larger as compared to that of AlGaAs/GaAs structures, leading
to a significant increase of the sheet carrier concentration at the interface [74].

The amount of charge density due to spontaneous charge density in case of AlGaN is 0.055 C/m2 [75].
The Amount of charge density because of piezoelectric polarization is given by
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𝑄𝑝𝑒 = 2

𝑎𝐺𝑎𝑁 −𝑎𝐴𝑙𝐺𝑎𝑁
(𝑒31
𝑎𝐴𝑙𝐺𝑎𝑁

− 𝑒33

𝐶13
)
𝐶33

(5.2)

where, a is the lattice constant of the material, e is the piezoelectric co-efficient and C is the relevant
elastic constant.

5.3

Non-linear Charge Control Model

The first model to predict the charge concentration at the heterojunction of a HEMT device was proposed
by D. Delagebeaudeuf and N. T. Linh [76]. Based on AlGaAs/GaAs HEMT, they proposed that the
charge concentration at the 2DEG is given by

𝑄𝑠 = 𝑞𝑛𝑠 =

𝜖2
𝑑

(𝑉𝑔 −

𝐸𝐹
𝑞

− 𝑉𝑜𝑓𝑓 )

where, Qs is the channel charge, ns is the sheet carrier density, ϵ2 is the permittivity of the higher bandgap
material, d is the effective distance between the Schottky gate and 2DEG, EF is the Fermi energy at the
interface, Vg is the applied gate voltage, and Voff is the voltage that annihilates the 2DEG and is given by

𝑉𝑜𝑓𝑓 = 𝜑𝐵 −

∆𝐸𝑐
𝑞

𝑞𝑁

𝑑

− 2𝜖 2 (𝑑 − 𝑒)2 − 𝜖 𝑄𝑖
2

2

(5.3)

where, φB is the Schottky barrier height, ΔEC is the conduction band offset at the hetero-interface, e is the
thickness of the spacer layer, Qi is the interface state charge.
Now, EF is dependent on Vg and results in a nonlinear equation for ns, and in case of a triangular potential
well, the relationship between EF and ns is given by [77]
2

𝐸𝐹 = 𝐸𝐹0 + 𝛾𝑛𝑠 3
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where, EF0 is equilibrium Fermi level and γ is a constant linking the 2DEG carrier density with the
longitudinal quantized energy. This approximation is valid as long as the device is not operated in the
deep subthreshold region.

dd
Δd
φB

EC

ΔEC
EF

GaN
Gold

EV

AlGaN

Figure 5.4: Energy band diagram of AlGaN/GaN HEMT.

For AlGaN/GaN HEMT devices, equation 5.3 can be modified depending on the Energy band diagram as
shown in Figure 5.4 as follows [78]:

𝑛𝑠 (𝑥) =

𝑄𝑠
𝑞

=

𝑞∈2
𝑞2 𝑑+∈2 𝑎

(𝑉𝑔 − 𝑉(𝑥) − 𝑉𝑡ℎ )
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(5.4)

where, a is the quantum well shape factor, V(x) is the channel potential at x, Vth is the threshold voltage,
and d = dd + dr +Δd, where dd is the thickness of AlGaN layer, dr is the roughness of gate metal and Δd is
the offset of the 2-DEG from the hetero-interface.
The threshold voltage Vth is given by
𝑉𝑡ℎ = 𝑉𝑜𝑓𝑓 + 𝐸𝐹
For AlGaN/GaN HEMT, Voff is defined by

𝑉𝑜𝑓𝑓 = 𝜑𝐵 −

∆𝐸𝑐
𝑞

𝑞𝑁

− 2𝜖 2 𝑑2
2

Using equation 5.4, the equation for sheet carrier density can be rewritten as

𝑛𝑠 (𝑥) =

5.4

𝑞∈2
𝑞 2 𝑑+∈

2𝑎

(𝑉𝑔 − 𝑉(𝑥) − 𝜑𝐵 +

∆𝐸𝑐
𝑞

+

𝑞𝑁2 2
𝑑
2𝜖2

2

− 𝐸𝐹0 − 𝛾𝑛𝑠 3 )

(5.5)

Current Voltage Characteristics

The drain current is given by [79],
𝐼𝑑 = 𝑞𝑛𝑠 𝑍𝑣(𝑥)

(5.6)

where, Z is the gate width and v(x) is the electron drift velocity. The relationship between the drift
velocity and the electric field used by in this work is expressed as [29],
𝑣(𝑥) =

𝑣𝑠 𝐸(𝑥)

(5.7)

𝑣 2
√𝐸 2 (𝑥)+( 𝑠 )
𝜇0

where, vs is the saturation drift velocity and μ0 is the low-field mobility.
Using equations 5.5 to 5.7, the drain current equation can be written as
𝑞2 ∈

𝐼𝑑 = 𝑞2 𝑑+∈2

2𝑎

(𝑉𝑔 − 𝑉(𝑥) − 𝜑𝐵 +

∆𝐸𝑐
𝑞

𝑞𝑁

2

+ 2𝜖 2 𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠 3 ) 𝑍
2
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𝑣𝑠 𝐸(𝑥)
𝑣 2
√𝐸 2 (𝑥)+( 𝑠 )
𝜇0

(5.8)

5.4.1

Drain Current Before Saturation

From the boundary conditions, it is obvious that V(x) = 0 at x = 0, and V(x) = Vds at x = L, where L is the
length of the HEMT.
From equation 5.8,
2
𝑞 2 ∈2
∆𝐸𝑐 𝑞𝑁2 2
= 2
(𝑉𝑔 − 𝜑𝐵 +
+
𝑑 − 𝐸𝐹0 − 𝛾𝑛𝑠 3 ) 𝑍
𝑞 𝑑 +∈2 𝑎
𝑞
2𝜖2

𝐼𝑑,0

𝑣𝑠 𝐸(𝑥)
𝑣 2
√𝐸 2 (𝑥) + ( 𝑠 )
𝜇
0

𝐼𝑑,𝐿 =

2
𝑞 2 ∈2
∆𝐸𝑐 𝑞𝑁2 2
3) 𝑍
(𝑉
−
𝑉
−
𝜑
+
+
𝑑
−
𝐸
−
𝛾𝑛
𝑔
𝑑𝑠
𝐵
𝐹0
𝑠
𝑞 2 𝑑 +∈2 𝑎
𝑞
2𝜖2

From equation 5.8,
2

𝐼𝑑 = 𝐾1 (𝑉𝑔 − 𝑉(𝑥) − 𝐾2 − 𝛾𝑛𝑠 3 ) 𝑍

𝑞2 ∈

where, 𝐾1 = 𝑞2 𝑑+∈2

2

and 𝐾2 = 𝜑𝐵 −
𝑎

∆𝐸𝑐
𝑞

𝑣𝑠 𝐸(𝑥)
√𝐸 2 (𝑥)+𝛽

𝑞𝑁

𝑣

2

0

So,
2

𝛽2
𝐸 2 (𝑥)

Since 𝐸(𝑥) = −

=

𝐾1 (𝑉𝑔 −𝑉(𝑥)−𝐾2 −𝛾𝑛𝑠 3 )𝑍𝑣𝑠
𝐼𝑑

−1

𝑑𝑉(𝑥)
,
𝑥

1/2

2

−𝛽𝑑𝑥 = {

2

− 2𝜖 2 𝑑2 + 𝐸𝐹0 , and 𝛽 2 = (𝜇𝑠 )

𝐾1 (𝑉𝑔 −𝑉(𝑥)−𝐾2 −𝛾𝑛𝑠 3 )𝑍𝑣𝑠
𝐼𝑑

Or,
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− 1}

𝑑𝑉(𝑥)

𝑣𝑠 𝐸(𝑥)
𝑣 2
√𝐸 2 (𝑥) + ( 𝑠 )
𝜇0

𝑑𝑉(𝑥) = −

𝛽
1/2
𝐺(𝑥)
(
−1)
𝐼𝑑

𝑑𝑥

(5.9)

2

where, 𝐺(𝑥) = 𝐾1 (𝑉𝑔 − 𝑉(𝑥) − 𝐾2 − 𝛾𝑛𝑠 3 (𝑥)) 𝑍𝑣𝑠 .

By integrating equation 5.9 from x = 0 to x = L, the drain current equation before saturation is obtained
using the boundary conditions.

5.4.2

Drain Current After Saturation

Saturation is achieved when channel conductance gm becomes zero.
𝑔𝑚 =

𝜕𝐼𝑑
𝜕𝑉𝑑𝑠

=0

Because of the current continuity at the onset of saturation,
𝑞2 ∈

𝐼𝑑,𝑠𝑎𝑡 = 𝑞2 𝑑+∈2

2𝑎

(𝑉𝑔 − 𝑉𝑑𝑠 − 𝜑𝐵 +

∆𝐸𝑐
𝑞

2

𝑞𝑁

+ 2𝜖 2 𝑑2 − 𝐸𝐹0 − 𝛾𝑛𝑠 3 ) 𝑍
2

𝑣𝑠 𝐸𝑠𝑎𝑡
2 +( 𝑣𝑠 )
√𝐸𝑠𝑎𝑡
𝜇0

2

(5.10)

𝑉

where, 𝐸𝑠𝑎𝑡 = − 𝐿𝑠𝑎𝑡 .
𝑠𝑎𝑡

To find out Vsat and Lsat, two dimensional Poisson’s equation in the pinch-off region can be solved which
results in [77]

𝑉𝑑 − 𝑉𝑠𝑎𝑡 =

2𝐸𝑠 𝑑𝑠
𝐿−𝐿
𝑠𝑖𝑛ℎ [ 2𝑑𝑠𝑎𝑡 ]
𝜋
𝑠

where,
𝜖 2/3
(𝑉𝑔
𝑞𝑑

𝑑𝑠 = 𝑑 {1 + 𝛾 ( 2 )

−1/3

− 𝑉𝑡ℎ − 𝑉𝑠𝑎𝑡 )
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}

5.5

Comparison of Measurement and Simulation Results

The current voltage characteristics of test devices are obtained by Keithley 4200 semiconductor parameter
analyzer and Signatone DC probe station. The transfer characteristics is obtained by keeping the drain to
source voltage constant. Figure 5.5 shows the comparison of measured and simulated Id – Vgs curve at Vds
= 5 V. The threshold voltage of the HEMT device is observed to be -4.56 V.
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Figure 5.5: Measured and simulated transfer characteristics (Id-Vgs) of the AlGaN/GaN HEMT device. Vds is kept
fixed at 5V.

The output characteristics is obtained at varying gate voltage by keeping Vgs constant a particular bias and
varying Vds from 0V to 5V. The drain current before saturation and after saturation are calculated using
equations 5.9 and 5.10. It is observed that the model overestimates the drain current at higher voltages,
since a constant resistant throughout the channel is considered.
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The output characteristics curves are measured for gate voltage of -2V to +2V by step increment. The
measured and simulated Id – Vds curve is shown in Figure 5.6. For low values of voltage, the simulated
curves match the measured output characteristics. But for higher voltages, some discrepancy is observed
since the as the secondary effects of the channel saturation such as channel length modulation become

Drain current, Id (mA)

prominent, which are ignored in the proposed model for the sake of simplicity.
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Figure 5.6: Measured and simulated output characteristics (Id-Vds) of HEMT device. Vgs is varied from -2V to +2V.
Vds is varied from 0V to 5V
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Chapter 6
Floating Gate Model for BioFET
6.1

Introduction

This chapter focuses on the development of a floating gate model suitable for predicting the behavior of
biosensor platform. The nonlinear charge control model for evaluation of the drain current as discussed in
the previous chapter depends on the applied gate voltage. But in case of biosensor, an applied gate voltage
will nullify any effect of the charged biomolecules immobilized on the gate surface. As such, a model is
required that predicts the modulation of the channel charge in response of the immobilized gate charge
instead of applied gate voltage.

This chapter explains the mechanism of how the charged biomolecules modulate the channel charge
underneath the gate and modifies the analytical model developed in the previous chapter into a floating
gate model.

6.2

Charge Coupling Through Gate Capacitance

Target biomolecules are immobilized on the gate by functionalization of the HEMT sensor. Once
immobilized, the charged biomolecules are linked to the channel charge via capacitive coupling method.
A positive charge on the gate will induce more electrons in the 2DEG below and result in the increase in
the drain current. A negative charge on the gate on the other hand will repel electrons from the 2DEG.
The loss of electron in the channel will be reflected via a reduction in the drain current. Since no external
voltage is applied, the configuration is considered to be a floating gate condition. The capacitive coupling
of the charge molecules will change the electric field distribution and as such will be reflected as floating
gate voltage.
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Cgc = Qfg / Vfg
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Figure 6.1: Schematic of floating gate AlGaN/GaN HEMT with gold contacts at gate, drain and source region.
Target biomolecules are adsorbed onto the gold contacts of the gate and become capacitively coupled to the channel
underneath.

The relationship between the floating gate charge Qfg, the reflected voltage at the floating gate Vfg, and the
gate-to-channel capacitance Cgc is simply given by
𝑄𝑓𝑔 = 𝐶𝑔𝑐 𝑉𝑓𝑔

(6.1)

This gate charge will affect the electrostatic distribution in the channel and modify the sheet carrier
density according to the following equations:

𝑛𝑠 =

𝑄𝑠
𝑞

=

𝑛𝑠 + ∆𝑛 =

∈2
𝑑

(𝜑𝑏 +

∈2
𝑑

𝐸𝐹
𝑞

(𝜑𝑏 +

−

𝐸𝐹
𝑞

∆𝐸𝑐
𝑞

−

+ 𝑉𝑐 (𝑥))

∆𝐸𝑐
𝑞

+ 𝑉𝑐 (𝑥) −

(6.2)

∆𝑑+𝑑𝑑
𝑉𝑓𝑔 )
𝑑

(6.3)

where, Qs is the channel charge, Δn is the modified sheet carrier density due to the floating gate voltage,
ϵ2 is the permittivity of AlGaN, φb is the Schottky barrier height, EF is the Fermi energy at the interface
relative to the GaN conduction-band-edge, ΔEC is the conduction band offset at the AlGaN/GaN interface,
VC(x) is the channel potential at x, and d = dd + dr +Δd, where dd is the thickness of AlGaN layer, dr is the
roughness of gate metal and Δd is the offset of the 2-DEG from the heterointerface.
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6.3

Current Voltage Characteristics

The sheet carrier density from equations 6.2 and 6.3 can be used to calculate the drain current before and
after the immobilization of the biomolecules via equations 6.4 and 6.5 as shown below,

𝐼𝐷 = 𝑞𝑛𝑠 𝑍𝜈(𝑥)

(6.4)

𝐼𝐷 + ∆𝐼𝐷 = 𝑞(𝑛𝑠 + ∆𝑛)𝑍𝜈(𝑥)

(6.5)

where, the drift velocity is replaced by the velocity-electric field empirical relationship of the previous
chapter and we get

𝐼𝐷 = 𝑞

𝐼𝐷 + ∆𝐼𝐷 = 𝑞

∈2
𝑑

∈2
𝑑

(𝜑𝑏 +

𝐸𝐹
𝑞

−

𝐸𝐹
𝑞

−

∆𝐸𝑐
𝑞

(𝜑𝑏 +

∆𝐸𝑐
𝑞

+ 𝑉𝑐 (𝑥)) 𝑍

+ 𝑉𝑐 (𝑥) −

𝜈𝑠 𝐸(𝑥)
𝜈
√𝐸 2 (𝑥)+( 𝑠 )
𝜇0

∆𝑑+𝑑𝑑
𝑉𝑓𝑔 ) 𝑍
𝑑

(6.6)

2

𝜈𝑠 𝐸(𝑥)
𝜈 2
√𝐸 2 (𝑥)+( 𝑠 )

(6.7)

𝜇0

where, vs is the saturation velocity of electrons in GaN, 0 is the low-field mobility of electron in the 2DEG.
The mechanism of change in drain current before and after the immobilization of biomolecules is shown
in Figure 6.2.
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Figure 6.2: Changes in the drain current due to biomolecule immobilization: (a) Current before immobilization of
biomolecules, (b) Current after the immobilization of biomolecules.

From equations 6.6 and 6.7, the change in the drain current due to the immobilized biomolecules can be
given by

∆𝐼𝐷 = 𝑞

∈2
𝑑

(−

∆𝑑+𝑑𝑑
𝑉𝑓𝑔 ) 𝑍
𝑑

𝜈𝑠 𝐸(𝑥)
𝜈 2
√𝐸 2 (𝑥)+( 𝑠 )
𝜇0
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(6.8)

6.4

Effect of Threshold Voltage Shift

The threshold voltage changes due to the dipoles of the target biomolecules, which can be written as [80,
81]
∆𝑉𝑡ℎ =

𝜇𝑑𝑖𝑝 𝑁𝑏

(6.9)

𝜖

where, µdip and ϵ are the dipole moment and the dielectric permittivity of the biomolecule, respectively, Nb
is the surface density of the charged molecules vertically oriented on the gate.

Under floating gate condition, the sheet carrier density, ns(x) is redefined from equation 5.5 by,
𝑛𝑠 (𝑥) + ∆𝑛𝑠 = 𝑞(𝑑

∈2
𝑑 +∆𝑑)

(−𝑉(𝑥) − 𝑉𝑡ℎ − ∆𝑉𝑡ℎ )

(6.10)

where, V(x) is the voltage along the x-direction in the 2-DEG channel due to applied drain bias [9, 10].
𝑉𝑡ℎ = 𝜑𝐵 −

∆𝐸𝑐
𝑞

−

𝑁𝑑𝑑
𝜖2

+

𝐸𝐹
𝑞

(6.11)

where, N is the sheet charge density due to spontaneous and piezoelectric polarizations.
From equations 6.9 to 6.11, the change in sheet carrier density due to shift in threshold voltage can be
expressed by

∆𝑛𝑠 = 𝑞(𝑑

𝜇 𝑁
∈2
(− 𝑑𝑖𝑝𝜖 𝑏 )
+∆𝑑)
𝑑

(6.12)

As such, the change in the drain current can be given by

∆𝐼𝐷 = (𝑑

𝜇𝑑𝑖𝑝 𝑁𝑏
∈2
(−
)𝑍
𝜖
𝑑 +∆𝑑)

𝜈𝑠 𝐸(𝑥)
𝜈 2
2
√𝐸 (𝑥)+( 𝑠 )
𝜇0
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(6.13)

6.5

Comparison of Measurement and Simulation Results

The changes in the drain current before and after the immobilization of the target biomolecules are
measured using Keithly 4200 semiconductor parameter analyzer and Signatone Checkmate probe station.
The measured test data is compared with the simulation results based on the proposed floating gate
model, as shown in Figure 6.3. For low values of drain voltage (upto 2V), the measured data closely
follows the simulation data.
It is also observed from test data that as biomolecule concentration at the gate increases, the drain current
reaches saturation at a lower reflected gate voltage. It is because increased biomolecule concentration at
the gate increases the net charge available at the gate. As a result, the required voltage to reach peak
current is decreased. This phenomenon is exhibited in Figure 6.4.
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20
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2

Drain to Source Voltage, VDS (V)

Figure 6.3: Simulated and measured changes in the drain current due to immobilization of target biomolecule.
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Figure 6.4: Variation in Vds at which peak differential current occurs with the increase in biomolecule
concentration. The x axis is shown in logarithmic scale for better comprehension.

61

Chapter 7
Discussions and Conclusions
6.1

Conclusions

Different biosensor platforms have been investigated in detail in this work. After careful comparison of
these biosensor platforms, AlGaN/GaN HEMT based biosensor platform is chosen for the detection of
multiple biomolecules. An analytical model considering the effect of polarization which forms a 2DEG in
a triangular quantum well is proposed. Based on the physics based analytical model, a floating gate model
has been derived to predict the behavior of the AlGaN/GaN HEMT based biosensor platform.

The original contributions, as pointed out by this work are:

 Configuring an AlGaN/GaN HEMT as a bioFET for the first time.
 Detection of multiple target biomolecules using the same platform.
 Measurement of target biomolecule (MIG) in physiologically relevant environment for the
first time.
 Improving the existing model of HEMT by including the effect of polarization which creates
the channel in AlGaN/GaN HEMT.
 Predicting the behavior of the proposed bioFET by modifying the proposed model in a
floating gate configuration.
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6.2

Future Works

Compared to Si technology, AlGaN/GaN devices are still at the preliminary stages of their development
and fabrication. As such, gate leakage, traps and surface defects are some still hinder the
commercialization of high performance wide bandgap GaN devices. But because of their immense
prospect, GaN might be the device of the future. As such, a physics-based analytical model to predict the
device behavior is of utmost importance. Including the effects of following phenomena would help
understand the device behavior more accurately:


Parasitic parallel conduction for higher gate voltage



Variation of drain and source resistances with gate voltage and temperature



Leakage currents



Trapping effects

In this work, the DC current-voltage characteristics of AlGaN/GaN HEMT have been validated by the
measured data. The proposed model is also used to predict the behavior of a biosensor realized in
AlGaN/GaN HEMT platform for two different kinds of biomolecules for in vitro sensing. The biosensor
platform can be improved by investing the following conditions:


Including the effect of interferers that might be present in relevant physiological

condition for in vivo sensing.


Validating the model using other charged biomolecules.



Developing a lab-on-a-chip platform by transferring the output of the HEMT to the signal

processing unit.
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